These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11802199)

  • 1. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
    Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
    Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage.
    Manne U; Jhala NC; Jones J; Weiss HL; Chatla C; Meleth S; Suarez-Cuervo C; Grizzle WE
    Clin Cancer Res; 2004 Mar; 10(5):1743-52. PubMed ID: 15014027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
    Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
    Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.
    Lim YJ; Kim YH; Ahn GH; Chun HK; Jang WY; Lee JH; Son HJ; Rhee PL; Kim JJ; Paik SW; Yoo BC; Rhee JC
    Korean J Gastroenterol; 2004 Dec; 44(6):314-20. PubMed ID: 15665575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.
    Manne U; Weiss HL; Myers RB; Danner OK; Moron C; Srivastava S; Grizzle WE
    Cancer; 1998 Dec; 83(12):2456-67. PubMed ID: 9874449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
    Bold RJ; Hess KR; Pearson AS; Grau AM; Sinicrope FA; Jennings M; McConkey DJ; Bucana CD; Cleary KR; Hallin PA; Chiao PJ; Abbruzzese JL; Evans DB
    J Gastrointest Surg; 1999; 3(3):263-77. PubMed ID: 10481119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship among p53, stage, and prognosis of large bowel cancer.
    Nathanson SD; Linden MD; Tender P; Zarbo RJ; Jacobsen G; Nelson LT
    Dis Colon Rectum; 1994 Jun; 37(6):527-34. PubMed ID: 8200229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
    Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
    Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of colorectal carcinomas using tissue microarrays: cell cycle regulatory proteins p21, p27, and p53 as immunohistochemical prognostic markers in univariate and multivariate analysis.
    Prall F; Ostwald C; Nizze H; Barten M
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):111-21. PubMed ID: 15354735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
    Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
    Cheng JD; Werness BA; Babb JS; Meropol NJ
    Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas.
    Tenjo T; Toyoda M; Okuda J; Watanabe I; Yamamoto T; Tanaka K; Ohtani M; Nohara T; Kawasaki H; Tanigawa N
    Oncology; 2000; 58(1):45-51. PubMed ID: 10644940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage.
    Georgiou L; Minopoulos G; Lirantzopoulos N; Fiska-Demetriou A; Maltezos E; Sivridis E
    J Surg Res; 2006 Mar; 131(1):118-23. PubMed ID: 16325858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
    Zlobec I; Steele R; Michel RP; Compton CC; Lugli A; Jass JR
    Mod Pathol; 2006 Sep; 19(9):1236-42. PubMed ID: 16741523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers for colorectal cancer: expression of P53 and BCL2.
    Pereira H; Silva S; Julião R; Garcia P; Perpétua F
    World J Surg; 1997 Feb; 21(2):210-3. PubMed ID: 8995081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.